Drug Profile
Anti-D RhO immunoglobulin - Kamada
Alternative Names: Anti-D immunoglobulin - Kamada; KamRho; KamRho (D) IM; KamRho (D) IVLatest Information Update: 19 May 2023
Price :
$50
*
At a glance
- Originator Kamada
- Developer Kamada; Vitel Laboratorios
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemolytic disease of newborn; Idiopathic thrombocytopenic purpura
Most Recent Events
- 31 Dec 2022 Launched for Haemolytic disease of newborn (Prevention) in Paraguay, Palestine (IM)
- 31 Dec 2022 Registered for Haemolytic disease of newborn (Prevention) in Paraguay, Costa Rica, Costa Rica, Thailand, India, Palestine (IM)
- 09 May 2017 Preregistration for Haemolytic disease of newborn (Prevention) in Mexico (IM)